Amneal Pharmaceuticals Ownership | Who Owns Amneal Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amneal Pharmaceuticals Ownership Summary


Amneal Pharmaceuticals is owned by 40.30% institutional investors, 50.66% insiders, and 9.04% retail investors. Vanguard group is the largest institutional shareholder, holding 4.79% of AMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.41% of its assets in Amneal Pharmaceuticals shares.

AMRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmneal Pharmaceuticals40.30%50.66%9.04%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.69%10.91%62.39%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group14.84M4.79%$117.55M
Blackrock funding, inc. /de12.59M4.07%$99.70M
Tpg gp a12.33M3.98%$97.64M
Blackrock11.28M3.67%$71.64M
Rubric capital management lp10.72M3.46%$84.92M
Dimensional fund advisors lp4.99M1.61%$39.53M
Geode capital management3.81M1.23%$30.21M
Neuberger berman group3.76M1.22%$29.79M
State street3.70M1.19%$29.29M
Nantahala capital management3.67M1.18%$29.03M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tucker asset management1.11M1.99%$8.80M
Tpg gp a12.33M1.58%$97.64M
Nantahala capital management3.67M1.25%$29.03M
Blackbarn capital partners lp2.85M1.24%$22.57M
Phocas financial201.89K1.19%$1.60M
Rubric capital management lp10.72M1.09%$84.92M
Hussman strategic advisors252.00K0.59%$2.00M
Jackson creek investment advisors201.93K0.48%$1.60M
Hennessy advisors1.67M0.39%$13.23M
Convergence investment partners208.01K0.37%$1.65M

Top Buyers

HolderShares% AssetsChange
Blackrock11.28M0.00%2.12M
Nantahala capital management3.67M1.25%995.59K
Acadian asset management1.72M0.04%546.74K
Millennium management1.32M0.01%506.97K
Blackbarn capital partners lp2.85M1.24%438.39K

Top Sellers

HolderShares% AssetsChange
Ubs group1.67M0.00%-20.11M
Fosun---1.72M
Lsv asset management---1.06M
Woodline partners lp567.06K0.03%-1.04M
Phocas financial201.89K1.19%-813.30K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial372.00K0.00%372.00K$2.95M
Balyasny asset management172.31K0.00%172.31K$1.36M
Jump financial165.92K0.03%165.92K$1.31M
Norges bank86.20K0.00%86.20K$547.37K
Pdt partners79.17K0.06%79.17K$627.02K

Sold Out

HolderChange
Global retirement partners-1.00
National bank of canada /fi/-2.00
Wr wealth planners-59.00
Covestor-78.00
Bessemer group-160.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241997.57%124,789,717-12.50%401.90%12132.97%41-28.07%
Sep 30, 2024183-0.54%141,484,8992.04%452.27%91-14.15%5624.44%
Jun 30, 20241832.81%138,650,46928.21%451.20%1056.06%45-
Mar 31, 202417816.34%108,142,002-0.95%611.23%9916.47%452.27%
Dec 31, 20231536.25%109,174,2827.09%701.61%85-1.16%4437.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.36M1.41%-
Vanguard US Total Market Shares ETF4.36M1.39%-
iShares Russell 2000 ETF4.21M1.34%-36.47K
Vanguard Small Cap Index3.56M1.15%2.90K
Vanguard Small Cap Value Index Inv2.35M0.76%-6.04K
Vanguard Institutional Extnd Mkt Idx Tr2.24M0.72%20.40K
Fidelity Small Cap Index1.57M0.50%-29.39K
Hennessy Cornerstone Growth Investor1.50M0.48%-171.20K
iShares Russell 2000 Growth ETF1.18M0.38%-5.64K
Columbia Small Cap Value II1.13M0.36%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 01, 2025Patel Gautam-Sell$664.00K
Mar 14, 2025Patel Tushar Bhikhubhai-Sell$41.75M
Mar 05, 2025BOYER ANDREW S Executive Vice PresidentSell$1.11M
Mar 06, 2025Daly Jason B. EVP, Chief Legal OfficerSell$409.75K
Mar 05, 2025Daly Jason B. EVP, Chief Legal OfficerSell$382.41K

Insider Transactions Trends


DateBuySell
2025 Q2-1
2025 Q1-10
2024 Q4-5
2024 Q3-3
2024 Q2-2

AMRX Ownership FAQ


Who Owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals shareholders are primarily institutional investors at 40.30%, followed by 50.66% insiders and 9.04% retail investors. The average institutional ownership in Amneal Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which Amneal Pharmaceuticals exceeds.

Who owns the most shares of Amneal Pharmaceuticals?

Amneal Pharmaceuticals’s largest shareholders are Vanguard group (14.84M shares, 4.79%), Blackrock funding, inc. /de (12.59M shares, 4.07%), and Tpg gp a (12.33M shares, 3.98%). Together, they hold 12.84% of Amneal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amneal Pharmaceuticals?

Yes, BlackRock owns 3.67% of Amneal Pharmaceuticals, totaling 11.28M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 71.64M$. In the last quarter, BlackRock increased its holdings by 2.12M shares, a 23.11% change.

Who is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tucker asset management is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.99% of its assets in 1.11M Amneal Pharmaceuticals shares, valued at 8.8M$.

Who is the top mutual fund holder of Amneal Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Amneal Pharmaceuticals shares, with 1.41% of its total shares outstanding invested in 4.36M Amneal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools